Molecular Systems Biology 7; Article number 499; doi:10.1038/msb.2011.31 Citation: Molecular Systems Biology 7:499

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Anti-psychotic drugs act synergistically in combination with antifungal drugs to inhibit drug-resistant Cryptococcus and Candida species

  2026cites this paper
• INTEGRATED TRANSCRIPTOMIC PROFILING OF THE Candida albicans RESPONSE TO THE SYNERGISTIC INTERACTION BETWEEN ATOMOXETINE AND FLUCONAZOLE

  2026cites this paper
• A screen to identify antifungal antagonists reveals a variety of pharmacotherapies that induce echinocandin tolerance in Candida albicans

  2025cites this paper
• A screen to identify antifungal antagonists reveals a variety of pharmacotherapies induce echinocandin tolerance in Candida albicans

  2025cites this paper
• Recent Advances in the Development of Antifungal Agents: Beyond Azoles, Polyenes, and Echinocandins.

  2025cites this paper
• Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species

  2024cites this paper
• Bioluminescent Pseudomonas aeruginosa and Escherichia coli for whole-cell screening of antibacterial and adjuvant compounds

  2024cites this paper
• Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses

  2024cites this paper
• Wiring Between Close Nodes in Molecular Networks Evolves More Quickly Than Between Distant Nodes

  2024cites this paper
• Calcium‐dependent antimicrobials: Nature‐inspired materials and designs

  2024cites this paper
• The atypical antipsychotic aripiprazole alters the outcome of disseminated Candida albicans infections

  2024cites this paper
• Halofantrine Hydrochloride Acts as an Antioxidant Ability Inhibitor That Enhances Oxidative Stress Damage to Candida albicans

  2024cites this paper
• Impact of sphingolipid synthesis inhibition on the drug susceptibility patterns of Trichophyton species.

  2024cites this paper
• The atypical antipsychotic aripiprazole alters the outcome of disseminated Candida albicans infections

  2024cites this paper
• New antifungal strategies: drug combination and co-delivery.

  2023cites this paper
• Wiring between close nodes in biological networks evolves more quickly than between distant nodes

  2023cites this paper
• Proteasome inhibition as a therapeutic target for the fungal pathogen Cryptococcus neoformans

  2023cites this paper
• Anti-Candidal Activity of Reboxetine and Sertraline Antidepressants: Effects on Pre-Formed Biofilms

  2023cites this paper
• Development and research progress of anti-drug resistant fungal drugs.

  2022cites this paper
• Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation

  2022cites this paper
• Small molecules for combating multidrug-resistant superbug Candida auris infections

  2022cites this paper
• Combining CRISPRi and metabolomics for functional annotation of compound libraries

  2022cites this paper
• Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?

  2022cites this paper
• Novel avenues for identification of new antifungal drugs and current challenges

  2022cites this paper
• Non-antifungal drugs inhibit growth, morphogenesis and biofilm formation in Candida albicans

  2021cites this paper
• What is the elephant in the room when considering new therapies for fungal diseases?

  2021cites this paper
• Repurposing benzimidazoles to fight Cryptococcus

  2021cites this paper
• Treatment strategies for cryptococcal infection: challenges, advances and future outlook

  2021cites this paper
• Repurposing the FDA‐approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species

  2021cites this paper
• Potentiated inhibition of Trichoderma virens and other environmental fungi by new biocide combinations

  2021cites this paper
• Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities

  2020cites this paper
• Combination Therapy to Treat Fungal Biofilm-Based Infections

  2020cites this paper
• The Future of Antifungal Drug Therapy: Novel Compounds and Targets

  2020cites this paper
• Antifungal Drug Repurposing

  2020influential citation
• Repurposing Nonantifungal Approved Drugs for Synergistic Targeting of Fungal Pathogens.

  2020cites this paper
• Alternative treatment of fungal infections: Synergy with non‐antifungal agents

  2020cites this paper
• Advances in fungal chemical genomics for the discovery of new antifungal agents

  2020cites this paper
• Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies

  2020cites this paper
• Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity

  2020cites this paper
• Darunavir inhibits Cryptococcus neoformans/Cryptococcus gattii species complex growth and increases the susceptibility of biofilms to antifungal drugs.

  2020cites this paper
• Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

  2020cites this paper
• Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species

  2020cites this paper
• New Approaches for Cryptococcosis Treatment

  2020cites this paper
• Antifungal drug screening: thinking outside the box to identify novel antifungal scaffolds.

  2020cites this paper
• A Histoplasma capsulatum Lipid Metabolic Map Identifies Antifungal Targets

  2020cites this paper
• Physiologically‐Based Pharmacokinetic Model of Sertraline in Human to Predict Clinical Relevance of Concentrations at Target Tissues

  2020cites this paper
• In vitro Antibiotic and Modulatory Activity of Mesosphaerum suaveolens (L.) Kuntze against Candida strains

  2020cites this paper
• Cryptococcosis: current treatment and new possibilities

  2020cites this paper
• Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections

  2019cites this paper
• Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics

  2019cites this paper
• Five-Feature Model for Developing the Classifier for Synergistic vs. Antagonistic Drug Combinations Built by XGBoost

  2019cites this paper
• Drug repurposing for antimicrobial discovery

  2019cites this paper
• A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.

  2019cites this paper
• Drug combinations: a strategy to extend the life of antibiotics in the 21st century

  2019cites this paper
• Antifungal drugs: New insights in research & development.

  2019cites this paper
• New pathogens, new tricks: emerging, drug‐resistant fungal pathogens and future prospects for antifungal therapeutics

  2019cites this paper
• Drug repurposing : fast-tracking antifungal drug discovery for cryptococcal meningitis

  2019cites this paper
• Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris

  2019cites this paper
• Sertraline Reduces Albuminuria by Interfering with Caveolae-Mediated Endocytosis through Glomerular Endothelial and Epithelial Cells

  2019cites this paper
• Calcium-Calmodulin-Calcineurin Signaling: A Globally Conserved Virulence Cascade in Eukaryotic Microbial Pathogens.

  2019cites this paper
• Étude de l'homéostasie de la taille chez la levure opportuniste Candida albicans

  2019cites this paper
• A Systematic Screen Reveals a Diverse Collection of Medications That Induce Antifungal Resistance in Candida Species

  2019cites this paper
• Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis

  2019cites this paper
• Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets

  2019cites this paper
• Can Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?

  2019cites this paper
• Design of high-order antibiotic combinations against M. tuberculosis by ranking and exclusion

  2019cites this paper
• Repurposing approach identifies phenylpentanol derivatives as potent azole chemosensitizing agents effective against azole-resistant Candida species

  2019cites this paper
• Immunomodulation as Therapy for Fungal Infection: Are We Closer?

  2018cites this paper
• Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs

  2018cites this paper
• Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis

  2018cites this paper
• Micro- and Nanoscale Approaches in Antifungal Drug Discovery

  2018cites this paper
• High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method.

  2018cites this paper
• Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease

  2018cites this paper
• Penetrating cations induce pleiotropic drug resistance in yeast

  2018cites this paper
• Cryptococcus neoformans mutant screening: a genome-scale's worth of function discovery

  2018cites this paper
• Functional analysis of selected deletion mutants in Candida glabrata under hypoxia

  2017cites this paper
• Design, Synthesis, and Biological Activity of New Triazole and Nitro-Triazole Derivatives as Antifungal Agents

  2017cites this paper
• Transcriptome and network analyses in Saccharomyces cerevisiae reveal that amphotericin B and lactoferrin synergy disrupt metal homeostasis and stress response

  2017cites this paper
• The antifungal pipeline: a reality check

  2017cites this paper
• High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance

  2017cites this paper
• Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.

  2017cites this paper
• Combinatorial strategies for combating invasive fungal infections

  2017cites this paper
• Molecular Evolution of Antifungal Drug Resistance.

  2017cites this paper
• Antifungal Activity of Antidepressant Sertraline against Candida Species In vitro : A Potential Beneficial Association with Fluconazole

  2017influential citation
• Antifungal adjuvants: Preserving and extending the antifungal arsenal

  2017influential citation
• Chemogenomic Profiling of the Fungal Pathogen Candida albicans

  2017cites this paper
• Using Yeast to Discover Inhibitors of Multidrug Efflux in Candida albicans

  2017cites this paper
• Antifungal Phenothiazines: Optimization, Characterization of Mechanism, and Modulation of Neuroreceptor Activity.

  2017cites this paper
• The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles

  2017cites this paper
• Potent Antifungal Synergy of Phthalazinone and Isoquinolones with Azoles Against Candida albicans.

  2017cites this paper
• Antifungals

  2017cites this paper
• Effi cacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis : an open-label dose-ranging study

  2016cites this paper
• Newer patents in antimycotic therapy.

  2016cites this paper
• In vitro synergistic effects of chlorpromazine and sertraline in combination with amphotericin B against Cryptococcus neoformans var. grubii

  2016cites this paper
• Psidium guajava L. and Psidium brownianum Mart ex DC.: Chemical composition and anti - Candida effect in association with fluconazole.

  2016cites this paper
• Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays.

  2016cites this paper
• A Fungal-Selective Cytochrome bc1 Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance.

  2016cites this paper
• New Horizons in Antifungal Therapy

  2016cites this paper
• Application of multivariate statistics and machine learning to phenotypic imaging and chemical high-content data

  2016cites this paper
• Quinone derivatives isolated from the endolichenic fungus Phialocephala fortinii are Mdr1 modulators that combat azole resistance in Candida albicans

  2016cites this paper